Maha: FDA to track TB patients

Tuberculosis (TB) is an infectious disease that usually affects the lungs. Many TB patients in Maharashtra and Mumbai are being treated by private doctors or at the hospitals. The government doesn’t have their information. To track these patients, the Food and Drug Administration (FDA) will conduct an inquiry with the chemists. In the upcoming days, the FDA and the TB eradication department officials will visit the chemists and collect the information of the TB patients and the medicines

Sewri TB hospital saves man’s life by performing complex surgery

  • The number of TB patients across the state and Mumbai, have gone up. Owing to which, the Food and Drug Administration (FDA) has come forward to curb the numbers.
  • The FDA has started inspecting the medicines given to the TB patients by the chemists.
  • The information will be collected about which doctor has prescribed the scheduled H1 drug which is highly sensitive, the name of the patient and the address.

 The number of patients taking treatment for TB from the private hospitals is very high. These officers will be working to keep records of the patients taking treatment from these private hospitals. The decision was taken in the meeting between the Food and Drug Administration Officer, State’s District Health Officer and the TB control officer. FDA has issued a circular regarding this.

Speaking to My Medical Mantra, Amrut Nikhade, joint commissioner (drugs), FDA, said, “The government is taking FDA’s help to track the newly detected TB patients. In the upcoming 24 hours, we will provide the list of all the chemists to the TB eradication department officials. The officers will go to every shop and find to whom the medicines were given. A letter has been sent to all the chemists by asking them to cooperate with the TB eradication department officials.”

 Vijay Singhvi, technical officer, FDA, “The government wants to make India TB free by 2025. For which, a campaign has been initiate to track the newly detected TB patients. After finding them, the government will give them the medicines free of cost. There are 47 highly sensitive medicines under scheduled H1 drug out of which 8 medicines are for TB. The sellers of these medicines have to keep a record. It consists of the name of the patient, address and the doctor’s name. Through which the TB patients will be tracked. Action will be taken against drug vendors who do not provide the information.”

 About the campaign:

  • It will be implemented throughout the state including Mumbai
  • At the end of the month, the information of the patients will be sent to the central government
  • The central government will take the help of the FDA
  • FDA has handed the list of over 50,000 chemists to the TB eradication department officials
  • The TB control officer will go to every shop to get information about H1 medicines
  • The FDA and the TB eradication department officials will visit the chemists and collect the information of the TB patients and the medicines